as 02-21-2025 4:00pm EST
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Founded: | 2013 | Country: | United States |
Employees: | N/A | City: | BRANFORD |
Market Cap: | 288.2M | IPO Year: | N/A |
Target Price: | $3.42 | AVG Volume (30 days): | 10.0M |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.63 | EPS Growth: | N/A |
52 Week Low/High: | $0.61 - $5.77 | Next Earning Date: | 03-03-2025 |
Revenue: | $2,266,000 | Revenue Growth: | 232.26% |
Revenue Growth (this year): | 193.9% | Revenue Growth (next year): | 173.18% |
QSI Breaking Stock News: Dive into QSI Ticker-Specific Updates for Smart Investing
Business Wire
4 days ago
Business Wire
9 days ago
Business Wire
10 days ago
Simply Wall St.
10 days ago
Business Wire
11 days ago
Business Wire
18 days ago
Business Wire
25 days ago
Business Wire
a month ago
The information presented on this page, "QSI Quantum-Si Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.